Funao N - Search Results

1

Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study.

Kawai T, Oda K, Funao N, Nishimura A, Matsumoto Y, Mizokami Y, Ashida K, Sugano K. Kawai T, et al. Among authors: funao n. Gut. 2018 Jun;67(6):1033-1041. doi: 10.1136/gutjnl-2017-314852. Epub 2017 Dec 1. Gut. 2018. PMID: 29196436 Free PMC article. Clinical Trial.

2

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study.

Murakami K, Sakurai Y, Shiino M, Funao N, Nishimura A, Asaka M. Murakami K, et al. Among authors: funao n. Gut. 2016 Sep;65(9):1439-46. doi: 10.1136/gutjnl-2015-311304. Epub 2016 Mar 2. Gut. 2016. PMID: 26935876 Free PMC article. Clinical Trial.

3

Reply to the letter by Dr Graham concerning ethical and interpretation issues with vonoprazan-containing H. pylori eradication therapy.

Murakami K, Sakurai Y, Shiino M, Funao N, Nishimura A, Asaka M. Murakami K, et al. Among authors: funao n. Gut. 2017 Feb;66(2):386. doi: 10.1136/gutjnl-2016-312011. Epub 2016 May 3. Gut. 2017. PMID: 27196601 No abstract available.

4

Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study.

Mizokami Y, Oda K, Funao N, Nishimura A, Soen S, Kawai T, Ashida K, Sugano K. Mizokami Y, et al. Among authors: funao n. Gut. 2018 Jun;67(6):1042-1051. doi: 10.1136/gutjnl-2017-314010. Epub 2017 Oct 7. Gut. 2018. PMID: 28988197 Free PMC article. Clinical Trial.

5

Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis.

Xiao Y, Zhang S, Dai N, Fei G, Goh KL, Chun HJ, Sheu BS, Chong CF, Funao N, Zhou W, Chen M. Xiao Y, et al. Among authors: funao n. Gut. 2020 Feb;69(2):224-230. doi: 10.1136/gutjnl-2019-318365. Epub 2019 Aug 13. Gut. 2020. PMID: 31409606 Free PMC article. Clinical Trial.

6

SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.

Inagaki N, Onouchi H, Sano H, Funao N, Kuroda S, Kaku K. Inagaki N, et al. Among authors: funao n. Lancet Diabetes Endocrinol. 2014 Feb;2(2):125-32. doi: 10.1016/S2213-8587(13)70149-9. Epub 2013 Nov 1. Lancet Diabetes Endocrinol. 2014. PMID: 24622716 Clinical Trial.

7

Vonoprazan 10 mg or 20 mg vs. lansoprazole 15 mg as maintenance therapy in Asian patients with healed erosive esophagitis: A randomized controlled trial.

Xiao Y, Qian J, Zhang S, Dai N, Chun HJ, Chiu C, Chong CF, Funao N, Sakurai Y, Eisner JD, Xie L, Chen M. Xiao Y, et al. Among authors: funao n. Chin Med J (Engl). 2024 Apr 20;137(8):962-971. doi: 10.1097/CM9.0000000000003068. Epub 2024 Mar 29. Chin Med J (Engl). 2024. PMID: 38654422 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters